Navigation Links
Validity of Baseline Concussion Tests Questioned
Date:6/11/2011

SATURDAY, June 11 (HealthDay News) -- Baseline concussion tests for athletes may do more harm than good in some cases, an expert warns.

Baseline concussion testing provides a baseline score of an athlete's cognitive abilities, such as reaction time, working memory and attention span. Athletes who suffer a concussion retake the test, and if there is a large decrease in the score, they are typically banned from play until their score improves.

But the tests, which are mandatory for hundreds of thousands of amateur and professional athletes in the United States, have a high "false negative" rate, according to Christopher Randolph, a neuropsychologist at Loyola University Health System.

A false negative result means the test shows an athlete has recovered from a concussion when they're actually still experiencing effects from the injury. As a result, an athlete might be allowed to return to play before it's safe.

Randolph analyzed the scientific literature and could not find a prospective, controlled study of the current version of the most common baseline concussion test, called ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing). Athletes take the 20-minute test on a computer.

"There is no evidence to suggest that the use of baseline testing alters any risk from sport-related concussion, nor is there even a good rationale as to how such tests might influence outcome," Randolph wrote in an article published in a recent issue of the journal Current Sports Medicine Reports.

Instead of relying on baseline concussion tests, medical staff on sports teams "may be better advised to rely upon their own clinical judgment, in conjunction with a validated symptom checklist, in making return-to-play decisions," for athletes who have suffered a concussion, Randolph suggested.

More information

The American Association of Neurological Surgeons has more about

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Baseline PSA predicts risk of death from prostate cancer
2. Early prostate cancer detection, screening: No benefit for men with low baseline PSA value
3. Does baseline concussion testing really reduce risks to athletes?
4. Simple Concussion Test Measures Reaction Time
5. Brain Injury Association of Washington Provides National Leadership in Concussion Safety & Awareness
6. Academic Impacts of Concussions for Students at Issue in House of Representatives
7. Parents Ill-Informed About Kids Concussion Risks
8. Concussions in young athletes on the rise
9. Concussion Rates Soar Among Younger Kids
10. Mayo Clinic Sports Medicine to host concussion summit
11. NFL Players With Concussions Sidelined Longer: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Validity of Baseline Concussion Tests Questioned
(Date:7/31/2015)... ... July 31, 2015 , ... ... a novel catheter that was developed for targeted delivery of fluids to selected ... being treated at Florida Hospital Tampa with the device that provides direct, local ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in two separate friendly contests. ... in Detroit and the second match will occur in Birmingham, Alabama at Legion Field. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to ... Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based call ... display logic shows the script components to the agent only when wanted, and allows ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies ... long-term and post-acute care providers understand the benefits of using medication management ...
(Date:7/31/2015)... Metamora, Michigan (PRWEB) , ... July 31, 2015 ... ... 100th baby at Beaumont Hospital's Karmanos Center for Natural Birth . ... mothers looking for a safe natural childbirth experience. With nurses and caregivers that ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... Law Requires Certification for Pharmacy Techs, 91% ... Support Standards in Every ... today by the,Pharmacy Technician Certification Board (PTCB) shows that Americans ... prepare prescriptions in pharmacies. The poll results,released today at the ...
... As companies transform their,call centers into service-to-sales operations, ... while maintaining a customer service,function. Because they play ... is one of the key factors behind a ... leaders recommend reducing spans of control by as,much ...
... Are you taking the proper steps,to ward off colds ... so, you could,win a trip to Orlando. The Florida ... healthy this season with the Stay Well. Play,Well. Florida ... should submit a 300-word essay describing their,best kept secrets ...
... State University has received a $5.7 million federal grant ... continue the development of community partnerships that strengthen families ... problems. , The new award will support PROSPER ... additional five years. The total award to Penn State ...
... panel to add it to list of ,probable, causes of ... on the night shifts at bars, convenience stores, hospitals and ... cancer. , That,s the conclusion of an international group of ... official list of "probable" carcinogens. , A team of scientists ...
... 5 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), ... of small molecule therapeutics for,the treatment of cancer, ... will participate on the "Better Drugs & Novel ... Capital Markets Healthcare Conference in New,York., The ...
Cached Medicine News:Health News:Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 2Health News:Managing the Service-to-Sales Cultural Transformation - Complimentary Excerpt Available from Best Practices 2Health News:Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 2Health News:PSU $5.7 million grant to help families and youth avoid substance abuse, behavior problems 2Health News:Night Shift Work May Heighten Risk for Cancer 2Health News:Night Shift Work May Heighten Risk for Cancer 3Health News:Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference 2
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
(Date:7/30/2015)... July 30, 2015 Eisai Inc. announced today ... the United States , European Union and ... MHLW, respectively) for eribulin, for the treatment of patients ... prior chemotherapy for advanced or metastatic disease. ... a pivotal global Phase 3 clinical trial (Study 309), ...
(Date:7/30/2015)... Japan , July 30, 2015 ... of the study to fulfill the post-marketing commitment ... the Pan European Multi-Database Bladder Cancer Risk ... retrospective matched cohort study, conducted in four European ... HCI) with up to 10 years of follow-up. ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... DIEGO, March 21, 2012  Millennium Laboratories announced today ... the course for more responsible and ethical business ... outlines the principles to which Millennium adheres and ... in the pain management industry to adopt. ...
... encourages continuous electronic monitoring, including the use of both ... analgesia (PCA). According to the Institute ... knowledge exist today to prevent errors associated with use ... says , "The solutions are available. We know ...
Cached Medicine Technology:Millennium Laboratories Announces Laboratory Responsibility Pledge 2Millennium Laboratories Announces Laboratory Responsibility Pledge 3Physician-Patient Alliance for Health & Safety: Hospitals Need to Address PCA Pump Patient Safety 2
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
Medicine Products: